We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





UV Disinfection Robot Neutralizes Coronavirus and Protects Patients and Healthcare Workers from COVID-19

By HospiMedica International staff writers
Posted on 21 Dec 2020
UV disinfection robots are being increasingly deployed across hospitals around the world to combat the novel coronavirus and further protect patients and healthcare workers from COVID-19.

UV disinfection company Surfacide’s (Waukesha, WI, USA) Helios System of UV robots are designed to help protect and keep patients and healthcare workers safe. More...
Surfacide's UV-C technology is scientifically proven to inactivate coronavirus - the family of viruses that make up SARS-CoV-2 and COVID-19. Surfacide is the world's first and only patented, automated, multiple-emitter UV-C system to safely eradicate harmful bacteria and viruses from environments. Surfacide’s Helios System uses multiple UV-C light towers simultaneously to rapidly eliminate and prevent the spread of dangerous microorganisms, including Coronavirus, SARS-CoV-2, C.diff, MRSA, VRE, CRE and Acinetobacter. Surfacide UV-C is scientifically proven to rapidly decontaminate SARS-CoV-2 (COVID-19) colonized surfaces, reducing virus and bacteria in a single cycle in as little as five minutes.

"We are grateful that so many pediatric hospitals have adopted Surfacide's powerful, trusted UV-C robot technology during these critical times," said Gunner Lyslo, Founder and CEO of Surfacide. "We are proud that Surfacide UV-C is having a positive impact in combating COVID-19 and protecting our most vulnerable young patients and all of the frontline essential healthcare workers that care for them."

Related Links:
Surfacide


New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Hybrid Arch Device
Neo EDE
New
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.